drugset
drugset / Trial / NCT04645485

Safety and Tolerability of Autologous Non-hematopoietic Peripheral Blood Stem Cells Therapy in Healthy Adult Volunteers.

NCT04645485 ↗

Phase 1 Completed 18 enrolled Abu Dhabi Stem Cells Center
NaSingle-groupOpen-labelTreatment

Summary

SANTANA Study is a phase 1, prospective, monocentric, open-label clinical trial involving healthy adult volunteers, with the objective to evaluate the safety and tolerability of the compressor nebulization of autologous non-hematopoietic peripheral blood stem cells (NHPBSC).

Timeline

Start
2020-05-12
Primary completion
2020-06-30
Completion
2020-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject autologous non-hematopoietic peripheral blood stem cells (NHPBSC) Cell therapy 10 ml Other

Indications

No indication recorded.